Evaluation of the Association Between Pulmonary Embolism, Laboratory and Clinical Parameters, and Pulmonary Involvement in COVID-19 Patients More Than 60 Years: A Single-Center Retrospective Study
Avicenna Journal of Aging and Healthcare · 29.08.2026 · 3 (1) · 14-18
DOI: 10.34172/ajah.4041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Avicenna Journal of Aging and Healthcare, online erschienen am 29.08.2026. Verfasst von Zahra Habibi und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
Coronavirus disease 2019 (COVID-19) is a viral infection that emerged in 2019. This infection causes a wide range of clinical manifestations, including pulmonary embolism (PE), which has been frequently reported in affected patients. Although numerous studies have investigated PE in patients with COVID-19, the relationship between PE, laboratory indices, and patient mortality has not been fully examined. Therefore, the present study aimed to address this issue.
Methods
In this retrospective study, patients were selected from those who were admitted to Hajar Hospital, Shahrekord, Iran, between 2020 and 2023. COVID-19 and PE were diagnosed based on laboratory tests and clinical symptoms by an infectious disease specialist. Following confirmation of the diagnosis, clinical records were retrieved from the hospital archives.
Results
Based on the results, the mean age, oxygen saturation, and pulmonary pressure were lower in patients with PE; however, the differences were not statistically significant (P>0.05). Furthermore, pulmonary involvement was slightly higher in patients with PE (P=0.37) than in those without PE. Moreover, the mean mortality rate was higher in patients with PE compared to those without PE, but the difference was not significant (P=0.70). The mean levels of lactate dehydrogenase (LDH), red blood cells (RBCs), hemoglobin (Hb), and ejection fraction (EF) were higher in individuals with PE, but these differences were not significant (P>0.05). By contrast, the mean levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), ferritin, white blood cell (WBC) count, and platelet count were higher in patients without PE (P>0.05).
Conclusion
Overall, the results demonstrated no significant relationship between clinical and laboratory parameters and the incidence of PE in COVID-19 patients.
Zitieren
APA
Habibi, Z., Mansouri, A., Sasani, M., Pirouz, L. R., & Zamanifard, S. (2026). Evaluation of the Association Between Pulmonary Embolism, Laboratory and Clinical Parameters, and Pulmonary Involvement in COVID-19 Patients More Than 60 Years: A Single-Center Retrospective Study. Avicenna Journal of Aging and Healthcare, 3(1), 14-18. https://doi.org/10.34172/ajah.4041
Vancouver
Habibi Z, Mansouri A, Sasani M, Pirouz LR, Zamanifard S. Evaluation of the Association Between Pulmonary Embolism, Laboratory and Clinical Parameters, and Pulmonary Involvement in COVID-19 Patients More Than 60 Years: A Single-Center Retrospective Study. Avicenna Journal of Aging and Healthcare. 2026;3(1):14-18. doi:10.34172/ajah.4041
BibTeX
@article{Habibi2026,
author = {Habibi, Zahra and Mansouri, Amir and Sasani, Mojtaba and Pirouz, Laya Rahmani and Zamanifard, Somayeh},
title = {Evaluation of the Association Between Pulmonary Embolism, Laboratory and Clinical Parameters, and Pulmonary Involvement in COVID-19 Patients More Than 60 Years: A Single-Center Retrospective Study},
journal = {Avicenna Journal of Aging and Healthcare},
year = {2026},
volume = {3},
number = {1},
pages = {14--18},
doi = {10.34172/ajah.4041}
}
EUVIMED